Skip to main content
. 2017 Jul 18;10:225. doi: 10.3389/fnmol.2017.00225

Table 1.

DNA methylation status of PD associated genes.

Gene Alias Location DNA methylation Reference
PAD2 Peptidyl arginine deiminase 2 1p36.13 No difference Mastronardi et al., 2007
ATP13A2 PARK9 1p36.13 No difference Behrens et al., 2010
DJ-1 PARK7 1p36.23 No methylation Tan Y. et al., 2016
NPAS2 Neuronal PAS2 2q11.2 Hypomethylation Lin et al., 2012
UCHL1 Ubiquitin C-terminal hydrolase L1 4p13 No difference Barrachina and Ferrer, 2009
PGC1-α Peroxisome proliferator-activated receptor gamma coactivator 1-alpha 4p15.2 Hypermethylation Su et al., 2015
TNF-α Tumor necrosis factor-alpha 6p21.33 No difference Pieper et al., 2008
PARK2 Parkinson juvenile disease protein 2, Parkin 6q26 No difference Cai et al., 2011
No difference De Mena et al., 2013
CYP2E1 Cytochrome P450-J 10q26.3 Hypomethylation Kaut et al., 2012
NOS2 Nitric oxide synthase 2 17q11.2 Hypomethylation Searles Nielsen et al., 2015
MAPT Microtubule associated protein Tau 17q21.31 Differential methylation Coupland et al., 2014
FANCC/TNKS2 Fanconi anemia group C protein/tankyrase 2 9q22.32/10q23.32 Differential methylation Moore et al., 2014
PARK16/GPNMB/STX1B PARK16/glycoprotein Nmb/syntaxin 1B 1q32/7p15.3/16p11.2 Differential methylation International Parkinson’s Disease Genomics Consortium [IPDGC], and Wellcome Trust Case Control Consortium 2 [WTCCC2]
Genome-wide Top 30 differentially methylated genes: KCTD5, VAV2, MOG, TRI M10, HLA-DQA1, ARHGEF10, GFPT 2, HLA-DRB5, TMEM9, MRI 1, MAPT, HLA-DRB6, LASS3, GSTTP 2, GSTTP. DNAJA3, JAKMIP 3, FRK, LRR C27, DMBX1, LGALS7, FOXK1, APBA1, MAGI2, SLC25A24, GSTT 1, MYOM2, MIR886, TUBA3E, TMCO3 Hypermethylation Hypomethylation Masliah et al., 2013

From left to right: Listed are genes, gene aliases, genomic locations (according to the latest GRCh38/hg38 assembly of the human genome available at the UCSC genome browser), DNA methylation status in PD and references.